{"name":"Prolacta Bioscience","slug":"prolacta-bioscience","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipwJBVV95cUxNT0ZsQUNITkpMMlZaTnVGZU9ERWVuczRhUFJZNGQ1OHZXLXVuZ3kyQ0NueE1RRmNNcklHbkNuUmF6N1p3cTNNT19lZHlENFhQaEphQmgzX0lKU1FEdlhhWjJqUXVVcGJpS2ZEN2psejdBbDQ4NW4xbWl5czJHQWZ6cEZGLVRaS3RwMms3X3l3S1U2T04yemxOM0l0dkttUnpDQXFvUzFmczhjYmU4OE1nblZWTjZZeFhwWEg2a3l6SWpHVFVuMmhKZzA3eXBjM2pLellmWE0tS2xuQnJZVnNwOWtmT3VRTjJ3SDlBNEczT0dkS2o3THlOb05USnhzblV0NXo0UU1OQ2FtWFhycHBZOEZPa1oteFRjbk4yQ1duNEJzSGVUM20w?oc=5","date":"2026-02-18","type":"regulatory","source":"PR Newswire","summary":"A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants - PR Newswire","headline":"A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQWXlnX0pReXBkdTg1WUc5VjhaZnlFWXUzQWxsLUJMZ0NpY0Y3TmN3UjNGeVo3ei1HbkRJLTlzSXVkUXg5WTRrRE54YmtTZ1NVaDI3ZE9jcXhuY0Y1TTRRWXdFZHdIeU9OeHU1ZzJsNThOd1ZmU3BqaWxaeF9Bd1c5Zy1tbndMUGxoVWVzUmlwTDdxcHh3bElnTw?oc=5","date":"2026-02-13","type":"regulatory","source":"Nutrition Insight","summary":"Japan approves Prolacta’s human milk-based fortifier for underweight infants as a pharmaceutical - Nutrition Insight","headline":"Japan approves Prolacta’s human milk-based fortifier for underweight infants as a pharmaceutical","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2026-02-12","type":"regulatory","source":"The Manila Times","summary":"Clinigen Announces World-First Pharmaceutical Approval for Prolacta Bioscience's PreemieFort® Enteral Solution, Human Milk-Based Product in Japan - The Manila Times","headline":"Clinigen Announces World-First Pharmaceutical Approval for Prolacta Bioscience's PreemieFort® Enteral Solution, Human Mi","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPRWNHQUc2LVhsYXJLemExVlNvS0JmdVRVb2pOM190cG5aOHY2UUs5SnRnd2lya0R3cUZhTjRaT3YwZ3V1Tng5X2t4ZkZ1VERienlFYlhuSEZNRzZqekdjeS16NlY2RVNwekhHQ0ktdlJoNElHV1JXTTNKYjlMYy1EelYxS3loUHozaTZQNVN5dEVRdHhYRGlvVVRfci1ERjUzMHRXSUdZZlBtWlJ6WHVHWjdnQlU?oc=5","date":"2025-02-25","type":"regulatory","source":"Pharmaceutical Executive","summary":"FDA Approves Prolacta Bioscience’s Surgifort for Infants Recovering from Gastroschisis Surgery - Pharmaceutical Executive","headline":"FDA Approves Prolacta Bioscience’s Surgifort for Infants Recovering from Gastroschisis Surgery","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE56bmktQVJmR3JaMjFiUHBlWHBLbW9KZzlzUGRwMV9ZdHUxa3ltN2Uwb3BfYU4wODFFR1hFeWpBQnZnNUJCWVY1b3pRZkxNXzFndmR4NnFObEN2MWNDNHZHTFFBRHBsWUk1cU5abGxUaGJRcS1lenJOSG5NWWk?oc=5","date":"2023-12-11","type":"pipeline","source":"Los Angeles Business Journal","summary":"Prolacta Starts Drug Development - Los Angeles Business Journal","headline":"Prolacta Starts Drug Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQdWlqeVNYX3pkMWJYcGtOcnBOeWFydTI1cjB5UlBVUDVScHRSNWhrLTFnTXJUME54a1JxRGFYVVB0ZDlubkNuR29BS0J6djhadTZLdFZXY1Q5ZzkxWFpicVp2UGFZamw1azBHdU9PVkdDUWh3bmVXZ3p3bTB2OUpsUVdFTUdSVHR6YnJBMWE2ZXRPT0UwZnpsT2pvYUdxNHB3NF9Yc3RjMU5Gd3M4WWwwVURxZ3hCU2d1QWc?oc=5","date":"2023-02-10","type":"pipeline","source":"Healio","summary":"As actinic keratosis cases increase, so do potential treatment options - Healio","headline":"As actinic keratosis cases increase, so do potential treatment options","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNdE52dlA3OC04TmdRbmhWZVo1enBYTVctWkphYkNfaW9Nbnh6M3JacEVzVHV4WlZsdzdXM1FoeURjbk53QWI5dVdUOXV2TVVsdWZhSnpTN0dCUElYTF80ZDNZdnhTYTUxNjNFZFJmQ1YzZEJCX1NBQmI3OWJxTnVZUjhXb3djZVFkNm1nbVo4cEUybF9VZGZpeU9zWUJsaFg5V3JNc3ZCZmxKRVlaN2JhVDl5THpONXdSeE1uV2MyY2x0MnYwNnc?oc=5","date":"2022-06-07","type":"pipeline","source":"PR Newswire","summary":"Prolacta Bioscience Appoints David Steinberg as Chief Financial Officer - PR Newswire","headline":"Prolacta Bioscience Appoints David Steinberg as Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxQN2tFdlFOb3UxODNwYkZuMzdKQ0Nob0VEbEFZRzJRMHZhX3VHM3VVaENVNEpjNmlWalNZajZMZ1pkVVFQRldvTEl1YW1EVllVTEVLTno3U0hjR1huU0NUT0tyYmJtX2FzRExRMmFHWW1DODQ2NUItNGt1VnR1LWtDSGFtSUk0ZHpIX2V2Vld1MWoxd05sZ1JuazlEZVphRndSVm1LV0dGSDV6VVlyaEYzUlNuVUhBQUhKNEpYSldLXzdDa2pId193eVBfVTFzR1JUQXk0d1daOVlaNGpKc1NKdGJaM3pqM0VpUWlWOGJKSzdDa3FzOXN2NC1Iaw?oc=5","date":"2022-01-18","type":"regulatory","source":"NutraIngredients.com","summary":"First for Japan: Prolacta Bioscience’s human milk-based fortifiers approved for clinical trial on premature infants - NutraIngredients.com","headline":"First for Japan: Prolacta Bioscience’s human milk-based fortifiers approved for clinical trial on premature infants","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQcm1qZUJVVmdJLXR1alJzWTlENXBHMGhlTHZYcWg1Sk9zT0trRkgxa1ZlRnJhNEtYVHhwSlBtdUl5eTluTnl5ZVZncnVUNTk0VjRkNXUwUmRDallpNk0zbU1rSDI4ZXpWS0FINzJGNkRmV3lfSmV4eWRzWGpYejhGVWlSWFlob0daSmFhUkg1M3Q?oc=5","date":"2015-03-20","type":"pipeline","source":"The New York Times","summary":"Breast Milk Becomes a Commodity, With Mothers Caught Up in Debate (Published 2015) - The New York Times","headline":"Breast Milk Becomes a Commodity, With Mothers Caught Up in Debate (Published 2015)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE1uN2R3LUxyenhPQjZqc0RvTmZEaVNwNmQ3dzB2UHBzVmx1NEs0RjRUcHhXcWxHZk9VcnN0NHF2MWlLRFFZY3BFTXVWa244VUNzZjZXakJubW9CU2stSHFWTVZMcTlhYTZJZ1hqUXplZG9EQQ?oc=5","date":"2014-11-28","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"30 Top VC Firms for Biotechs - Genetic Engineering and Biotechnology News","headline":"30 Top VC Firms for Biotechs","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}